CVS HEALTH CORPORATION Proceeds from Debt, Net of Issuance Costs
CVS HEALTH CORPORATION (CVS) had Proceeds from Debt, Net of Issuance Costs of $4.00 billion as of 2025-08-15, per its 10-K filed 2026-02-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2026-02-10
- CVS HEALTH CORPORATION proceeds from debt, net of issuance costs for the quarter ending 2020-03-31 was $3.95B.
- CVS HEALTH CORPORATION proceeds from debt, net of issuance costs for the quarter ending 2018-09-30 was $0.00.
- CVS HEALTH CORPORATION proceeds from debt, net of issuance costs for the quarter ending 2018-06-30 was $0.00.
- CVS HEALTH CORPORATION proceeds from debt, net of issuance costs for the quarter ending 2018-03-31 was $39.38B.
- CVS HEALTH CORPORATION proceeds from debt, net of issuance costs for fiscal 2020 was $1.99B.
| Period end | Proceeds from Debt, Net of Issuance Costs | Proceeds from Debt, Net of Issuance Costs as first filed | Proceeds from Debt, Net of Issuance Costs 1 month | Proceeds from Debt, Net of Issuance Costs 3 month | Proceeds from Debt, Net of Issuance Costs 6 month | Proceeds from Debt, Net of Issuance Costs 9 month | Proceeds from Debt, Net of Issuance Costs 12 month |
|---|---|---|---|---|---|---|---|
| 2025-08-15 | $4.00B 10-K · filed 2026-02-10 | ||||||
| 2024-12-10 | $3.00B 10-K · filed 2026-02-10 | ||||||
| 2024-05-09 | $5.00B 10-K · filed 2026-02-10 | ||||||
| 2023-06-02 | $4.90B 10-K · filed 2025-02-12 | ||||||
| 2023-05-01 | $5.00B 10-K · filed 2025-02-12 | ||||||
| 2023-02-28 | $6.00B 10-K · filed 2025-02-12 | ||||||
| 2023-02-21 | $6.00B 10-K · filed 2025-02-12 | ||||||
| 2021-08-18 | $987.00M 8-K · filed 2023-05-25 | ||||||
| 2020-12-31 | $1.99B 10-K · filed 2021-02-16 | ||||||
| 2020-08-21 | $3.97B 10-K · filed 2022-02-09 | ||||||
| 2020-03-31 | $3.95B 10-Q · filed 2020-11-06 | $3.95B 10-K · filed 2021-02-16 | |||||
| 2019-08-15 | $3.46B 10-K · filed 2021-02-16 | $3.50B 10-Q · filed 2019-11-06 | |||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 derived: sum of 2 quarters · filed 2018-11-06 | $39.38B 10-Q · filed 2018-11-06 | ||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $39.38B 10-Q · filed 2018-08-08 | |||||
| 2018-03-31 | $39.38B 10-Q · filed 2018-05-02 | ||||||
| 2016-05-16 | $3.50B 8-K · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |